$SNSS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Viracta Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Viracta Therapeutics, Inc.. Get notifications about new insider transactions in Viracta Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 01 2015 | SNSS | SUNESIS PHARMACEUT ... | Kim Helen Susan | Director | Option Exercise | A | 3.01 | 40,000 | 120,400 | 40,000 | |
Jul 01 2015 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 3.01 | 40,000 | 120,400 | 40,000 | |
Jul 01 2015 | SNSS | SUNESIS PHARMACEUT ... | Pearce Homer L | Director | Option Exercise | A | 3.01 | 40,000 | 120,400 | 40,000 | |
Jul 01 2015 | SNSS | SUNESIS PHARMACEUT ... | STUMP DAVID C | Director | Option Exercise | A | 3.01 | 40,000 | 120,400 | 40,000 | |
Jul 01 2015 | SNSS | SUNESIS PHARMACEUT ... | YOUNG JAMES W | Director | Option Exercise | A | 3.01 | 40,000 | 120,400 | 40,000 | |
Mar 02 2015 | SNSS | SUNESIS PHARMACEUT ... | Craig Adam R | EVP, Development & ... | Payment of Exercise | F | 2.22 | 8,302 | 18,430 | 23,452 | 31.8 K to 23.5 K (-26.14 %) |
Mar 02 2015 | SNSS | SUNESIS PHARMACEUT ... | Craig Adam R | EVP, Development & ... | Grant | A | 0.00 | 19,031 | 0 | 31,754 | 12.7 K to 31.8 K (+149.58 %) |
Mar 02 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Payment of Exercise | F | 2.22 | 7,723 | 17,145 | 49,913 | 57.6 K to 49.9 K (-13.40 %) |
Mar 02 2015 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Grant | A | 0.00 | 17,642 | 0 | 57,636 | 40 K to 57.6 K (+44.11 %) |
Mar 02 2015 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Payment of Exercise | F | 2.22 | 12,274 | 27,248 | 175,824 | 188.1 K to 175.8 K (-6.53 %) |
Mar 02 2015 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Grant | A | 0.00 | 30,330 | 0 | 188,098 | 157.8 K to 188.1 K (+19.22 %) |
Nov 03 2014 | SNSS | SUNESIS PHARMACEUT ... | Craig Adam R | EVP, Development & ... | Option Exercise | A | 1.70 | 140,000 | 238,000 | 140,000 | |
Nov 03 2014 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Option Exercise | A | 1.70 | 140,000 | 238,000 | 140,000 | |
Nov 03 2014 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | A | 1.70 | 300,000 | 510,000 | 300,000 | |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | SANDELL SCOTT D | 10% Owner | Sell | S | 7.51 | 11,600 | 87,070 | 4,659,333 | 4.7 M to 4.7 M (-0.25 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | SANDELL SCOTT D | 10% Owner | Sell | S | 7.87 | 146,800 | 1,154,846 | 4,670,933 | 4.8 M to 4.7 M (-3.05 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | SANDELL SCOTT D | 10% Owner | Sell | S | 8.17 | 108,300 | 884,811 | 4,817,733 | 4.9 M to 4.8 M (-2.20 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 7.51 | 11,600 | 87,070 | 4,659,333 | 4.7 M to 4.7 M (-0.25 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 7.87 | 146,800 | 1,154,846 | 4,670,933 | 4.8 M to 4.7 M (-3.05 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 8.17 | 108,300 | 884,811 | 4,817,733 | 4.9 M to 4.8 M (-2.20 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | KERINS PATRICK J | 10% Owner | Sell | S | 7.51 | 11,600 | 87,070 | 4,659,333 | 4.7 M to 4.7 M (-0.25 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | KERINS PATRICK J | 10% Owner | Sell | S | 7.87 | 146,800 | 1,154,846 | 4,670,933 | 4.8 M to 4.7 M (-3.05 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | KERINS PATRICK J | 10% Owner | Sell | S | 8.17 | 108,300 | 884,811 | 4,817,733 | 4.9 M to 4.8 M (-2.20 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | DRANT RYAN D | 10% Owner | Sell | S | 7.51 | 11,600 | 87,070 | 4,659,333 | 4.7 M to 4.7 M (-0.25 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | DRANT RYAN D | 10% Owner | Sell | S | 7.87 | 146,800 | 1,154,846 | 4,670,933 | 4.8 M to 4.7 M (-3.05 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | DRANT RYAN D | 10% Owner | Sell | S | 8.17 | 108,300 | 884,811 | 4,817,733 | 4.9 M to 4.8 M (-2.20 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BASKETT FOREST | 10% Owner | Sell | S | 7.51 | 11,600 | 87,070 | 4,659,333 | 4.7 M to 4.7 M (-0.25 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BASKETT FOREST | 10% Owner | Sell | S | 7.87 | 146,800 | 1,154,846 | 4,670,933 | 4.8 M to 4.7 M (-3.05 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BASKETT FOREST | 10% Owner | Sell | S | 8.17 | 108,300 | 884,811 | 4,817,733 | 4.9 M to 4.8 M (-2.20 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BARRIS PETER J | 10% Owner | Sell | S | 7.51 | 11,600 | 87,070 | 4,659,333 | 4.7 M to 4.7 M (-0.25 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BARRIS PETER J | 10% Owner | Sell | S | 7.87 | 146,800 | 1,154,846 | 4,670,933 | 4.8 M to 4.7 M (-3.05 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BARRIS PETER J | 10% Owner | Sell | S | 8.17 | 108,300 | 884,811 | 4,817,733 | 4.9 M to 4.8 M (-2.20 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BARRETT M JAMES | 10% Owner | Sell | S | 7.51 | 11,600 | 87,070 | 4,659,333 | 4.7 M to 4.7 M (-0.25 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BARRETT M JAMES | 10% Owner | Sell | S | 7.87 | 146,800 | 1,154,846 | 4,670,933 | 4.8 M to 4.7 M (-3.05 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BARRETT M JAMES | 10% Owner | Sell | S | 8.17 | 108,300 | 884,811 | 4,817,733 | 4.9 M to 4.8 M (-2.20 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 7.51 | 11,600 | 87,070 | 4,659,333 | 4.7 M to 4.7 M (-0.25 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 7.87 | 146,800 | 1,154,846 | 4,670,933 | 4.8 M to 4.7 M (-3.05 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 8.17 | 108,300 | 884,811 | 4,817,733 | 4.9 M to 4.8 M (-2.20 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 7.89 | 3,740 | 29,490 | 85,872 | 89.6 K to 85.9 K (-4.17 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 7.89 | 196,260 | 1,547,530 | 4,506,300 | 4.7 M to 4.5 M (-4.17 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 8.16 | 1,883 | 15,371 | 89,612 | 91.5 K to 89.6 K (-2.06 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 8.16 | 98,817 | 806,643 | 4,702,560 | 4.8 M to 4.7 M (-2.06 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 7.89 | 3,740 | 29,490 | 4,593,687 | 4.6 M to 4.6 M (-0.08 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 7.89 | 196,260 | 1,547,530 | 4,597,427 | 4.8 M to 4.6 M (-4.09 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 8.16 | 1,883 | 15,371 | 4,793,687 | 4.8 M to 4.8 M (-0.04 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 8.16 | 98,817 | 806,643 | 4,795,570 | 4.9 M to 4.8 M (-2.02 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Craig Adam R | EVP, Development & ... | Sell | S | 8.00 | 2,554 | 20,432 | 12,723 | 15.3 K to 12.7 K (-16.72 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Option Exercise | M | 1.74 | 10,000 | 17,400 | 115,000 | |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Sell | S | 8.00 | 10,000 | 80,000 | 39,994 | 50 K to 40 K (-20.00 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Buy | M | 1.74 | 10,000 | 17,400 | 49,994 | 40 K to 50 K (+25.00 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | M | 2.09 | 5,000 | 10,450 | 710,611 | |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Sell | S | 8.00 | 5,000 | 40,000 | 154,073 | 159.1 K to 154.1 K (-3.14 %) |
Aug 29 2014 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Buy | M | 2.09 | 5,000 | 10,450 | 159,073 | 154.1 K to 159.1 K (+3.25 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 6.77 | 694 | 4,700 | 4,894,387 | 4.9 M to 4.9 M (-0.01 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 6.77 | 36,406 | 246,531 | 4,895,081 | 4.9 M to 4.9 M (-0.74 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 6.90 | 591 | 4,079 | 4,931,487 | 4.9 M to 4.9 M (-0.01 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 6.90 | 31,009 | 214,024 | 4,932,078 | 5 M to 4.9 M (-0.62 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 6.62 | 12,622 | 83,559 | 4,963,087 | 5 M to 5 M (-0.25 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 6.62 | 662,378 | 4,385,009 | 4,975,709 | 5.6 M to 5 M (-11.75 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | SANDELL SCOTT D | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | SANDELL SCOTT D | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | DRANT RYAN D | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | DRANT RYAN D | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | KERINS PATRICK J | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | KERINS PATRICK J | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BASKETT FOREST | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BASKETT FOREST | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Jul 01 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 6.52 | 20,000 | 130,400 | 20,000 | |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BARRIS PETER J | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BARRIS PETER J | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.77 | 694 | 4,700 | 91,495 | 92.2 K to 91.5 K (-0.75 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.77 | 36,406 | 246,531 | 4,801,377 | 4.8 M to 4.8 M (-0.75 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.90 | 591 | 4,079 | 92,189 | 92.8 K to 92.2 K (-0.64 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.90 | 31,009 | 214,024 | 4,837,783 | 4.9 M to 4.8 M (-0.64 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.62 | 12,622 | 83,559 | 92,780 | 105.4 K to 92.8 K (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Sell | S | 6.62 | 662,378 | 4,385,009 | 4,868,792 | 5.5 M to 4.9 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BARRETT M JAMES | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | BARRETT M JAMES | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 6.76 | 35,540 | 240,190 | 4,926,033 | 5 M to 4.9 M (-0.72 %) |
Aug 12 2014 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Sell | S | 6.62 | 675,000 | 4,468,568 | 4,961,573 | 5.6 M to 5 M (-11.98 %) |
Jul 01 2014 | SNSS | SUNESIS PHARMACEUT ... | Fust Matthew | Director | Option Exercise | A | 6.52 | 20,000 | 130,400 | 20,000 | |
Jul 01 2014 | SNSS | SUNESIS PHARMACEUT ... | Carchedi Steve | Director | Option Exercise | A | 6.52 | 20,000 | 130,400 | 20,000 | |
Jul 01 2014 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Option Exercise | A | 6.52 | 20,000 | 130,400 | 20,000 | |
Jul 01 2014 | SNSS | SUNESIS PHARMACEUT ... | Pearce Homer L | Director | Option Exercise | A | 6.52 | 20,000 | 130,400 | 20,000 | |
Jul 01 2014 | SNSS | SUNESIS PHARMACEUT ... | Kim Helen Susan | Director | Option Exercise | A | 6.52 | 20,000 | 130,400 | 20,000 | |
Jul 01 2014 | SNSS | SUNESIS PHARMACEUT ... | STUMP DAVID C | Director | Option Exercise | A | 6.52 | 20,000 | 130,400 | 20,000 | |
Jul 01 2014 | SNSS | SUNESIS PHARMACEUT ... | YOUNG JAMES W | Director | Option Exercise | A | 6.52 | 20,000 | 130,400 | 20,000 | |
May 19 2014 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | M | 2.09 | 24,389 | 50,973 | 715,611 | |
May 19 2014 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Buy | M | 2.09 | 24,389 | 50,973 | 152,406 | 128 K to 152.4 K (+19.05 %) |
Apr 02 2014 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Option Exercise | M | 2.09 | 10,503 | 21,951 | 82,445 | |
Apr 02 2014 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Option Exercise | M | 2.09 | 19,551 | 40,862 | 92,948 | |
Apr 02 2014 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Sell | S | 5.08 | 10,503 | 53,364 | 73,961 | 84.5 K to 74 K (-12.43 %) |
Apr 02 2014 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Buy | M | 2.09 | 10,503 | 21,951 | 84,464 | 74 K to 84.5 K (+14.20 %) |
Apr 02 2014 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Sell | S | 5.03 | 19,551 | 98,295 | 73,961 | 93.5 K to 74 K (-20.91 %) |
Apr 02 2014 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Buy | M | 2.09 | 19,551 | 40,862 | 93,512 | 74 K to 93.5 K (+26.43 %) |
Mar 04 2014 | SNSS | SUNESIS PHARMACEUT ... | DePinto Joseph I | EVP, CCO | Option Exercise | A | 6.55 | 50,000 | 327,500 | 50,000 | |
Mar 04 2014 | SNSS | SUNESIS PHARMACEUT ... | DePinto Joseph I | EVP, CCO | Option Exercise | A | 6.55 | 250,000 | 1,637,500 | 250,000 | |
Mar 04 2014 | SNSS | SUNESIS PHARMACEUT ... | Craig Adam R | EVP, Development & ... | Option Exercise | A | 6.55 | 140,000 | 917,000 | 140,000 | |
Mar 04 2014 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Option Exercise | A | 6.55 | 125,000 | 818,750 | 125,000 | |
Mar 04 2014 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | A | 6.55 | 300,000 | 1,965,000 | 300,000 | |
Mar 04 2014 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Payment of Exercise | F | 6.55 | 3,747 | 24,543 | 128,017 | 131.8 K to 128 K (-2.84 %) |
Mar 04 2014 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Grant | A | 6.55 | 9,971 | 65,310 | 131,764 | 121.8 K to 131.8 K (+8.19 %) |
Jul 02 2013 | SNSS | SUNESIS PHARMACEUT ... | YOUNG JAMES W | Director | Option Exercise | A | 5.19 | 20,000 | 103,700 | 20,000 | |
Jul 02 2013 | SNSS | SUNESIS PHARMACEUT ... | STUMP DAVID C | Director | Option Exercise | A | 5.19 | 20,000 | 103,700 | 20,000 | |
Jul 02 2013 | SNSS | SUNESIS PHARMACEUT ... | Pearce Homer L | Director | Option Exercise | A | 5.19 | 20,000 | 103,700 | 20,000 | |
Jul 02 2013 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 5.19 | 20,000 | 103,700 | 20,000 | |
Jul 02 2013 | SNSS | SUNESIS PHARMACEUT ... | Kim Helen Susan | Director | Option Exercise | A | 5.19 | 20,000 | 103,700 | 20,000 | |
Jul 02 2013 | SNSS | SUNESIS PHARMACEUT ... | Fust Matthew | Director | Option Exercise | A | 5.19 | 20,000 | 103,700 | 20,000 | |
Jul 02 2013 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Option Exercise | A | 5.19 | 20,000 | 103,700 | 20,000 | |
Jul 02 2013 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Option Exercise | A | 5.19 | 20,000 | 103,700 | 20,000 | |
Jul 02 2013 | SNSS | SUNESIS PHARMACEUT ... | Carchedi Steve | Director | Option Exercise | A | 5.19 | 30,000 | 155,550 | 30,000 | |
Jun 19 2013 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | M | 2.09 | 10,000 | 20,900 | 740,000 | |
Jun 19 2013 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | M | 2.94 | 15,000 | 44,100 | 110,000 | |
Jun 19 2013 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Buy | M | 2.09 | 10,000 | 20,900 | 122,093 | 112.1 K to 122.1 K (+8.92 %) |
Jun 19 2013 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Buy | M | 2.94 | 15,000 | 44,100 | 112,093 | 97.1 K to 112.1 K (+15.45 %) |
Mar 01 2013 | SNSS | SUNESIS PHARMACEUT ... | Craig Adam R | EVP, Development & ... | Option Exercise | A | 5.22 | 125,000 | 652,500 | 125,000 | |
Mar 01 2013 | SNSS | SUNESIS PHARMACEUT ... | Craig Adam R | EVP, Development & ... | Grant | A | 0.00 | 7,662 | 0 | 10,257 | 2.6 K to 10.3 K (+295.26 %) |
Mar 01 2013 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Option Exercise | A | 5.22 | 100,000 | 522,000 | 100,000 | |
Mar 01 2013 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Payment of Exercise | F | 5.22 | 2,599 | 13,567 | 33,994 | 36.6 K to 34 K (-7.10 %) |
Mar 01 2013 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Grant | A | 0.00 | 7,088 | 0 | 36,593 | 29.5 K to 36.6 K (+24.02 %) |
Mar 01 2013 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | A | 5.22 | 300,000 | 1,566,000 | 300,000 | |
Mar 01 2013 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Payment of Exercise | F | 5.22 | 7,623 | 39,792 | 94,122 | 101.7 K to 94.1 K (-7.49 %) |
Mar 01 2013 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Grant | A | 0.00 | 20,785 | 0 | 101,745 | 81 K to 101.7 K (+25.67 %) |
Jul 02 2012 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Option Exercise | A | 2.87 | 25,000 | 71,750 | 25,000 | |
Jul 02 2012 | SNSS | SUNESIS PHARMACEUT ... | Fust Matthew | Director | Option Exercise | A | 2.87 | 25,000 | 71,750 | 25,000 | |
Jul 02 2012 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Director | Option Exercise | A | 2.87 | 25,000 | 71,750 | 25,000 | |
Jul 02 2012 | SNSS | SUNESIS PHARMACEUT ... | Kim Helen Susan | Director | Option Exercise | A | 2.87 | 25,000 | 71,750 | 25,000 | |
Jul 02 2012 | SNSS | SUNESIS PHARMACEUT ... | Pearce Homer L | Director | Option Exercise | A | 2.87 | 25,000 | 71,750 | 25,000 | |
Jul 02 2012 | SNSS | SUNESIS PHARMACEUT ... | STUMP DAVID C | Director | Option Exercise | A | 2.87 | 25,000 | 71,750 | 25,000 | |
Jul 02 2012 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 2.87 | 25,000 | 71,750 | 25,000 | |
Jul 02 2012 | SNSS | SUNESIS PHARMACEUT ... | YOUNG JAMES W | Director | Option Exercise | A | 2.87 | 30,000 | 86,100 | 30,000 | |
Mar 02 2012 | SNSS | SUNESIS PHARMACEUT ... | Craig Adam R | EVP, Development & ... | Option Exercise | A | 1.74 | 600,000 | 1,044,000 | 600,000 | |
Mar 02 2012 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Option Exercise | A | 1.74 | 125,000 | 217,500 | 125,000 | |
Mar 02 2012 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Payment of Exercise | F | 1.74 | 6,363 | 11,072 | 25,859 | 32.2 K to 25.9 K (-19.75 %) |
Mar 02 2012 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | EVP, CFO & Corp. Se ... | Grant | A | 0.00 | 17,349 | 0 | 32,222 | 14.9 K to 32.2 K (+116.65 %) |
Mar 02 2012 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | A | 1.74 | 425,000 | 739,500 | 425,000 | |
Mar 02 2012 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Payment of Exercise | F | 1.74 | 20,226 | 35,193 | 74,522 | 54.3 K to 74.5 K (+37.25 %) |
Mar 02 2012 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Grant | A | 0.00 | 55,143 | 0 | 94,748 | 39.6 K to 94.7 K (+139.23 %) |
Nov 30 2011 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Buy | P | 1.14 | 2,500 | 2,850 | 127,176 | 124.7 K to 127.2 K (+2.01 %) |
Nov 22 2011 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Buy | P | 1.18 | 2,100 | 2,478 | 45,616 | 43.5 K to 45.6 K (+4.83 %) |
Jul 18 2011 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Buy | P | 1.99 | 5,000 | 9,936 | 43,516 | 38.5 K to 43.5 K (+12.98 %) |
Jul 05 2011 | SNSS | SUNESIS PHARMACEUT ... | YOUNG JAMES W | Director | Option Exercise | A | 2.09 | 60,000 | 125,400 | 60,000 | |
Jul 05 2011 | SNSS | SUNESIS PHARMACEUT ... | STUMP DAVID C | Director | Option Exercise | A | 2.09 | 50,000 | 104,500 | 50,000 | |
Jul 05 2011 | SNSS | SUNESIS PHARMACEUT ... | Pearce Homer L | Director | Option Exercise | A | 2.09 | 50,000 | 104,500 | 50,000 | |
Jul 05 2011 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 2.09 | 50,000 | 104,500 | 50,000 | |
Jul 05 2011 | SNSS | SUNESIS PHARMACEUT ... | Kim Helen Susan | Director | Option Exercise | A | 2.09 | 50,000 | 104,500 | 50,000 | |
Jul 05 2011 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Option Exercise | A | 2.09 | 50,000 | 104,500 | 50,000 | |
Jul 05 2011 | SNSS | SUNESIS PHARMACEUT ... | Fust Matthew | Director | Option Exercise | A | 2.09 | 50,000 | 104,500 | 50,000 |